The SWI-SNF complex is required for the expression of a number of diversely regulated genes in the yeast Saccharomyces cerevisiae. The results of genetic experiments indicate that the SWI-SNF requirement reflects the ability of the complex to antagonize chromatin-mediated transcriptional repression (26) . In these studies, mutations in genes that encode chromatin components, including HHT1 (encoding histone H3), HHF1 (encoding histone H4), and SIN1 (encoding an HMG-1-like protein which is thought to be a chromatin component), were found to alleviate the transcriptional defects of swi mutants (14, 15) . In addition, alteration of relative histone levels by deletion of one of the two endogenous HTA1-HTB1 gene clusters (encoding histones H2A and H2B) is also able to partially restore transcriptional activity to swi-snf cells (12) . These results suggest that the SWI-SNF complex acts to promote the expression of genes within the context of a compact eukaryotic genome.
The primary level of chromatin architecture in vivo is the nucleosome. The results of in vivo and in vitro studies indicate that nucleosomes inhibit transcription by competing with transcription factors for occupancy of DNA binding sites (for a review, see reference 27). In vitro, nucleosomes can inhibit transcription initiation either by blocking access of the general transcription machinery to promoter sequences or by hindering the binding of upstream activator proteins. It is not known at present which of these steps might be overcome by the SWI-SNF complex in vivo. The results of biochemical studies have shown that yeast or human SWI-SNF complex can stimulate the binding of an activator protein to a nucleosomal binding site (5, 16) . Furthermore, the purified human SWI-SNF complex can facilitate the binding of the general transcription factor TATA box binding protein (TBP) to a positioned nucleosome (13) . Therefore, the SWI-SNF complex may function at one or more discrete steps to facilitate gene expression in vivo.
In this study, we address the ability of the SWI-SNF complex to facilitate the binding of a transcriptional activator to upstream activation sites (UASs). To do this, we monitored the transcriptional activity and DNA binding of the yeast activator GAL4 to derivatives of the UAS of the divergently transcribed GAL1 and GAL10 genes. These UAS derivatives differ in the affinity of the GAL4 binding sites as well as the nucleosomal context of these sites. We find that the SWI-SNF complex is required for GAL4 to activate transcription from a promoter containing two low-affinity, nucleosomal binding sites in vivo.
In addition, we show that the SWI-SNF dependence of this promoter reflects, in part, the ability of the complex to facilitate GAL4 binding to these nucleosomal sites.
MATERIALS AND METHODS
␤-Galactosidase assays. Strains were grown in minimal medium containing 2% galactose, 0.5% sucrose, and all the amino acids except histidine to an optical density at 600 nm (OD 600 ) of 0.5 to 0.9. Assays were performed (23) on three transformants, and Miller units (19) were averaged. Standard deviations were Ͻ25%. ␤-Galactosidase activity from all strains in the absence of GAL4 expression was Ͻ1 Miller unit.
In vivo footprinting. Intact cells were treated with dimethyl sulfate (DMS), and the methylated DNA was isolated essentially as previously described (10), except final pellets were dissolved in water and quantitated with a spectrophotometer. DNA samples were then digested with HaeIII and analyzed via a cyclic primer extension reaction (1) using a labeled oligonucleotide. Primer extension products were extracted with chloroform-isoamyl alcohol (24:1), precipitated, and electrophoresed on a 5% National Diagnostics sequencing gel. The gel was dried and exposed to film for 12 to 48 h. For a control for spurious primer extension products, DNA from a strain that was not treated with DMS was also prepared. Footprinting at the wild-type GAL1,10 UAS (see Fig. 2 ) was analyzed by using an oligonucleotide with the following sequence: 5Ј-GAG CCC CAT TAT CTT AGC-3Ј, which anneals to a sequence located 60 bp upstream of GAL4 binding site 1. Footprinting at the integrated reporter loci (see Fig. 3 ) was analyzed by using an oligonucleotide with the following sequence: 5Ј-CCG GCT CGT ATG TTG TGT GG-3Ј. This oligonucleotide anneals to the unique pUC sequences located upstream of the GAL4 binding sites in the reporters (see below).
Indirect end labeling. Nuclei were prepared as described previously (22) . To prepare free DNA, 80 l of 10% sodium dodecyl sulfate (SDS) and 30 l of 20-mg/ml proteinase K were added to a 1-ml aliquot of nuclei (approximately 5 ϫ 10 9 cell equivalents), and the sample was incubated at 37°C for 2 h. Lysed nuclei were treated with 180 l of 5 M potassium acetate on ice for 1 h and subjected to centrifugation, and the supernatant was precipitated with isopropanol. This DNA sample was resuspended in water and reprecipitated with ethanol. The resultant free DNA was resuspended in 1 ml of buffer D2 (10 mM HEPES [pH 7.3], 5 mM MgCl 2 , 2 mM CaCl 2 ). Free DNA and nuclei samples (approximately 1.7 ϫ 10 9 cell equivalents in 300-l aliquots) were digested with 0 to 50 U of micrococcal nuclease (MNase) for 5 min at 37°C. Reactions were halted by adding 26 l of 10% SDS and 10 l of 20-mg/ml proteinase K and incubating the mixtures at 37°C for 2 h. Samples were treated with 60 l of 5 M potassium acetate on ice for 1 h and subjected to centrifugation, and the supernatant was precipitated with isopropanol. DNA was then digested with either ClaI (see Fig.  4A and B) or EcoRI (see Fig. 4C ) in the presence of RNase. Digested fragments were extracted with buffered phenol, and the aqueous layer was precipitated with ethanol. Final pellets were electrophoresed on a 1.5% agarose gel overnight. DNA was transferred to a nylon membrane, and blots were probed with an internally labeled 870-bp lacZ fragment (see Fig. 4A and B) or an internally labeled 550-bp fragment from the GAL1 gene (see Fig. 4C ).
HgaI restriction enzyme accessibility assay. Permeabilized spheroplasts were prepared from exponentially growing cells (OD 600 of 0.6, in glucose medium) by treatment with yeast lyticase (24) . Briefly, cells were harvested, resuspended in 1/10 culture volume of prespheroplasting buffer (100 mM Tris [pH 8.0], 60 mM ␤-mercaptoethanol), and shaken for 10 min at room temperature. Cells were harvested and resuspended in 1/20 culture volume of spheroplasting buffer (0.7 M sorbitol, 0.75% yeast extract, 1.5% peptone, 10 mM Tris [pH 7.5], 10 mM ␤-mercaptoethanol), lyticase was added, and cells were incubated at 37°C until the OD 600 of cells diluted with water was decreased by 90% (30 to 40 min). Spheroplasts were harvested by centrifugation, washed once with nystatin buffer (50 mM NaCl, 1.5 mM CaCl 2 , 20 mM Tris [pH 8], 1 M sorbitol, 10 mM MgCl 2 ), and resuspended in 1/150 culture volume of nystatin buffer. Nystatin was added to a final concentration of 15 g/ml, and spheroplasts were incubated at 37°C for 5 min. HgaI (New England BioLabs) was added to the permeabilized spheroplasts at a concentration of 120 U/ml, and samples were incubated at 37°C for 0 to 30 min. Reactions were stopped by the addition of 1/5 volume of 5% SDS-50 mM EDTA, and DNA was purified as described above (a negative control lacked HgaI). Purified DNA was digested with HindIII (New England BioLabs), electrophoresed on a 1.5% agarose gel, Southern blotted to a nylon membrane, and probed with a 500-bp EcoRI fragment from plasmid pLB8 that was internally labeled by random priming (see Fig. 5 ). Results were quantitated by phosphorimager analysis.
Plasmid and strain construction. The following plasmids have been described previously: pRY171 (GAL1-lacZ fusion [30] ), pEG202 (pLEXA [11] ), and pMA210 (pGAL4) and pSD15 (17) . Plasmids pLB7 and pLB8 were constructed by inserting the 194-bp SmaI-PvuII fragment of pUC18 (29) between the URA3 gene and the GAL4 binding sites of the plasmids pEG44 and pEG28, respectively (9) . Plasmid pEG28 contains GAL4 binding sites 3 and 4 positioned 190 bp upstream of the GAL1 TATA element. These sites are separated by 62 bp (center-to-center distance). Plasmid pEG44 contains two synthetic, consensus GAL4 binding sites positioned 150 bp upstream of the GAL1 TATA element (9) . These two sites are separated by 32 bp (center-to-center distance). These plasmids were targeted for integration at the ura3-52 locus of yeast strains CY524, CY525, and CY526 (Table 1 ) by digestion with ApaI. A DNA fragment containing the 5S nucleosome positioning element (NPE) of sea urchin was amplified from plasmid pICN5S182 (gift from Jerry Workman) by PCR using the following primers: 5Ј-CCACGAATAACTTCCAGGG-3Ј and 5Ј-CCCCGAGGAATTAA GTAC-3Ј (18) . The 182-bp PCR product was inserted into plasmid pLB8, 20 bp upstream of GAL4 binding site 3 (see Fig. 1 ). This new plasmid, called pLB16, was targeted for integration at the ura3-52 locus of CY524, CY525, and CY526 by digestion with ApaI. Yeast transformations were performed via the lithium acetate method described previously (8) .
RESULTS
SWI-SNF activity is required for transcriptional activation by GAL4 at some promoters. Isogenic SWI ϩ and swi Ϫ strains that contain similar single-copy integrated reporters were constructed and are shown schematically in ) contain a reporter which contains two high-affinity, consensus GAL4 binding sites in place of the two low-affinity sites (reporter d) (9) . ␤-Galactosidase assays were performed on these strains to monitor GAL4 transcriptional activity either in the presence of endogenous concentrations of GAL4 (pLEXA columns) or under conditions in which GAL4 is overexpressed (pGAL4 columns) (Fig. 1A) .
In the absence of functional SWI-SNF complex, transcriptional activation by GAL4 from the wild-type GAL1,10 UAS region is reduced only 1.5-fold from the activity in the respective wild-type strain (Fig. 1A , reporter a). This result is consistent with a previous study in which it was found that GAL1 expression was only weakly affected by swi-snf mutations (21) . In contrast, GAL4 activity on the two reporters with two lowaffinity GAL4 binding sites is SWI-SNF dependent; transcriptional activity is reduced 22-to 32-fold in the swi1 Ϫ strains from that of the wild-type strain (Fig. 1A , reporters b and c). When these two low-affinity sites are replaced by two highaffinity, consensus GAL4 binding sites, transcriptional activation is reduced only 1.3-fold in the swi1 Ϫ strain from that of the wild-type strain (Fig. 1A, reporter d) .
Strains harboring the two low-affinity site reporters were also distinct from those carrying the two high-affinity site reporters in that lacZ expression was increased 2.5-to 3.5-fold when GAL4 protein was overexpressed (Fig. 1A , reporters b and c; also data not shown). The simplest interpretation of this result is that physiological levels of GAL4 are not sufficient to fully occupy the two low-affinity sites (9; also see below). Importantly, overexpression of GAL4 does not overcome the SWI-SNF dependence of this reporter (Fig. 1A, reporters b and c). It should be noted that the swi1 mutation does not affect expression of GAL4 from this overexpression plasmid in this strain background (Fig. 1B) (20) .
SWI-SNF is required for GAL4 occupancy of low-affinity binding sites in vivo. To directly assess the ability of GAL4 to bind its sites in the different reporter strains in the presence or absence of SWI-SNF, we used an in vivo DMS footprinting assay. GAL4 protects guanine residues at each end of its 17-bp recognition site both in vivo (10) and in vitro (3). As shown in Fig. 2 , these guanine residues within the four GAL4 binding sites of the GAL1,10 UAS are protected from DMS methylation in the presence of GAL4 (lane 3) but are accessible to methylation in an isogenic gal4 Ϫ strain (lane 2). Introduction of GAL4 expression plasmids into the gal4 Ϫ strain restores protection of these guanines (lanes 6 and 8), while introduction of a plasmid expressing the bacterial LexA protein does not (lane 7). In the absence of SWI-SNF activity, protection of all four sites is retained (lane 4). Furthermore, as shown in Fig.  3A , GAL4 also protects the guanine residues at each of the two high-affinity binding sites in the presence (lane 4) and absence (lane 5) of SWI-SNF. Similar results were obtained in at least six different experiments with five independent DNA preparations. These results are consistent with the results of our functional experiments (Fig. 1) in which SWI-SNF is not required for the activity of GAL4 from either the wild-type GAL1,10 UAS or the two-high-affinity-site reporter. Figure 3B shows the results of an in vivo footprinting analysis of the two-low-affinity-site reporter in strains CY532 (SWI ϩ ) and CY534 (swi1 Ϫ ). We detect little protection of the two low-affinity sites in our footprinting assay, even in a SWI ϩ strain (lane 3). As discussed above, this probably reflects the low occupancy of these sites at physiological GAL4 levels, because when GAL4 is overexpressed in this SWI ϩ strain, protection is restored (lane 5). Overexpression of GAL4 in the absence of a functional SWI-SNF complex, however, does not restore complete protection of either low-affinity binding site (lane 6). This is most apparent at GAL4 site 3, where strong protection in the SWI ϩ strain (lane 5) and are only weak protection in the swi1 Ϫ strain (lane 6) are observed. Quantitation of these results by phosphorimager analysis indicates that protection of the relevant guanine residue in site 3 in the swi1 Ϫ strain is decreased (40%) from that seen in a wild-type strain. For an internal control, we also analyzed these samples for GAL4 binding at the endogenous GAL1,10 UAS locus. In all cases, we observe complete occupancy of the four GAL4 sites in the presence and absence of SWI-SNF (data not shown). The lack of complete occupancy at the two low-affinity sites in the swi1 Ϫ strain indicates that the SWI-SNF complex modulates GAL4 binding in vivo.
Introduction of an NPE into a SWI-SNF-dependent promoter region can suppress the requirement for SWI-SNF. The results of genetic and biochemical experiments have indicated that SWI-SNF complex facilitates activator function by disrupting chromatin structure. To assess whether the chromatin structure of the GAL4 binding sites was related to their SWI-SNF dependence, a strong NPE was inserted directly upstream of the two low-affinity binding sites in strains CY532 (SWI ϩ ) and CY534 (swi1 Ϫ ). This 182-bp NPE sequence has been shown previously to translationally and rotationally position a nucleosome in vivo in yeast (20) (Fig. 4B) . Insertion of the NPE had a dramatic effect on the SWI-SNF dependence of GAL4 function. While GAL4 transcriptional activity at the parental two-low-affinity-site reporter was decreased over 20-fold in the absence of SWI-SNF (Fig. 1A, reporters b and c) , there was less than a 1.5-fold decrease when the NPE was inserted (Fig. 1A, reporter e) . This effect of the NPE is not due
FIG. 1. GAL4 requires functional SWI-SNF complex to activate transcription from two low-affinity binding sites. (A) ␤-Galactosidase assays were performed on isogenic SWI
ϩ or swi1 Ϫ strains harboring the integrated GAL1-lacZ UAS reporter plasmids pRY171 (a), pEG28 (b), pLB8 (c), pLB7 (d), or pLB16 (e). GAL4 binding sites are denoted by the small black boxes. GAL4 sites numbered 1 to 4 indicate sites from the GAL1,10 UAS region; GAL4 sites numbered 17 indicate synthetic, consensus GAL4 binding sites. Strains contained plasmids that overexpressed either the bacterial LexA DNA binding domain (pEG202) or the full-length GAL4 protein (pMA210). Numbers in parentheses show activities as percentages of the wild-type levels. ␤-Galactosidase activities of all reporters were Ͻ1 Miller unit in the absence of GAL4. Drawings are not to scale. n.d., not determined. (B) Western blot analysis of GAL4 levels. Whole-cell extracts (21) were prepared from equal numbers of SWI ϩ (CY296) and swi1 Ϫ (CY297) cells containing the GAL4 overexpression plasmid pMA210. Expression of GAL4 protein (indicated by the arrow) was identified by Western blotting using an antibody directed against the C terminus of GAL4 (21).
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simply to insertion of foreign DNA sequences directly upstream of the two low-affinity GAL4 binding sites, as insertion of 192 bp of pUC plasmid sequences at an identical position does not alter the SWI-SNF dependence of GAL4 activity (Fig.  1A , reporters b and c).
Nucleosomal context of GAL4 binding sites dictates SWI-SNF dependence.
The results of functional experiments described above suggest that the SWI-SNF dependence of GAL4 can be modulated by nucleosome positioning. In the case of the GAL1,10 locus, the four GAL4 binding sites are maintained in a constitutive nucleosome-free region which is flanked on both sides by an array of positioned nucleosomes (6, 7) (Fig. 4 ). This precise nucleosome positioning at the GAL1,10 locus is believed to require the GRF2 protein which binds to a sequence that overlaps GAL4 binding sites 1 and 2 (4, 7). The GAL1,10 UAS derivatives that we have analyzed in this study (Fig. 1A , reporters b to e) lack this GRF2 binding site, and therefore, they may not maintain nucleosome positioning surrounding the GAL4 binding sites. To confirm this possibility, we analyzed the chromatin structure of the twolow-affinity-site reporters (with and without an NPE) and compared these structures to that of the GAL1 locus in the same strains.
Nuclei and free DNA were prepared from the SWI ϩ strain CY532, which contains the parental two-low-affinity-site reporter (without an NPE), and samples were analyzed by MNase digestion and indirect end labeling. First, we analyzed the chromatin structure at the GAL1 locus in this reporter strain (Fig. 4C) . Comparison of the MNase cleavage patterns for free and chromatin DNA samples reveals a repeating pattern of MNase protections (each about 140 bp in size) flanked on each side by MNase-hypersensitive sites. These results are essentially identical to a previous study (6) and are consistent with an array of positioned nucleosomes downstream of the nucleosome-free GAL4 binding sites.
A similar analysis of the two-low-affinity-site reporter locus (without an NPE) yielded very different results (Fig. 4A) . In the region upstream of the two GAL4 binding sites, the MNase digestion pattern of the chromatin sample is similar to the pattern of digestion of free DNA, although we do reproducibly observe several preferred cleavage sites in free DNA that appear to be enhanced in the chromatin sample. Importantly, the MNase cleavage sites directly upstream and adjacent to the GAL4 binding sites are cleaved with equal efficiency in the free and chromatin DNA samples. A region of about 80 bp that contains the GAL4 binding sites is not cleaved efficiently in either the free or chromatin DNA samples; this is due to the inherent sequence specificity of MNase I and is not due to a positioned nucleosome (6) . In addition, this protected region is not flanked on both sides by hypersensitive sites. Directly downstream of the GAL4 binding sites, however, a 140-bp region of MNase resistance is detected, which is flanked on each side by MNase-hypersensitive sites, suggesting the presence of a positioned nucleosome. The location of this nucleosome corresponds to a positioned nucleosome mapped between the GAL4 sites and the GAL1 TATA box of the endogenous GAL1,10 locus (2, 6) ( Fig. 4C and data not  shown) . Thus, although one nucleosome still appears to be positioned at this GAL1,10 UAS derivative, the majority of nucleosome positioning has been lost. Consequently, nucleosomes appear to be located randomly upstream of the two remaining GAL4 binding sites. In the absence of a positioned array of nucleosomes, the two low-affinity GAL4 binding sites are unlikely to reside in a constitutive nucleosome-free region.
MNase digestions and indirect end labeling were also used to confirm that the NPE positioned a nucleosome upstream of the two low-affinity GAL4 binding sites (Fig. 4B) . Comparison of the free and chromatin DNA samples reveals an MNaseprotected region of about 250 bp which contains the NPE sequences as well as the MNase-resistant GAL4 binding site sequences. This result is consistent with the positioning of a nucleosome over the NPE sequence. In addition, the putative positioned nucleosome located directly downstream of the two low-affinity GAL4 binding sites is also detected at the NPEcontaining reporter locus in CY586 (Fig. 4B) .
These results are consistent with the model shown in Fig. 6 . In the absence of the NPE, the two low-affinity GAL4 binding sites are encompassed by randomly positioned nucleosomes; FIG. 2. GAL4 can bind its sites in the GAL1,10 UAS region in the presence or absence of SWI-SNF. In vivo DMS footprinting analysis of the GAL1,10 UAS region was performed on strains CY341 (SWI ϩ GAL4 ϩ ) (lane 3), CY257 (swi1
, CY296 containing a GAL4 expression plasmid (pMA210 or pSD15) (lanes 6 and 8), and CY296 containing a LexA expression plasmid (pEG202) (lane 7). Lane 1 contains a genomic guanine sequencing ladder. Boxes to the left of the gel denote the GAL4 binding sites of the GAL1,10 UAS, and asterisks denote guanine residues shown previously to be protected by GAL4 binding.
insertion of the NPE repositions the GAL4 binding sites into a nucleosome-free region between two positioned nucleosomes (see Fig. 6 ). To further test the possibility that insertion of the NPE changes the accessibility of the GAL4 binding sites, we investigated the ability of a restriction enzyme to cleave a site within GAL4 site 3 in permeabilized spheroplasts (Fig. 5 ). Spheroplasts were prepared from the SWI ϩ strains CY532 (which contains the parental two-low-affinity-site reporter) and CY586 (which harbors the NPE-containing two-low-affinitysite reporter). Spheroplasts were made permeable by treatment with nystatin (24) and incubated with HgaI restriction endonuclease for 15 to 30 min. Genomic DNA was then purified and digested to completion with HindIII, and the HgaI-HindIII cleavage products were analyzed by Southern blotting using a DNA probe from the GAL1 upstream region. This DNA probe will detect the HgaI-HindIII cleavage products derived from the GAL1,10 locus (1.6 kb) or the reporter locus (0.5 kb) in the same DNA sample (see the schematic in Fig. 5A ). In the case of the GAL1,10 locus, we expected that the HgaI site within GAL4 site 3 would be highly accessible in permeabilized spheroplasts, since this GAL4 site is known to be nucleosomefree (6) . In contrast, the model presented in Fig. 6 predicts that the HgaI site at the parental two-low-affinity-site reporter will be less accessible than the same site present at GAL1,10. Furthermore, the model predicts that insertion of the NPE will enhance the accessibility of the HgaI site at the reporter locus. Figure 5B shows the phosphorimager quantitation of a typical HgaI accessibility assay. At 15 and 30 min of digestion, HgaI cleavage at the GAL1,10 locus was nearly complete (value set at 100%) (data not shown). However, in the case of the FIG. 3 . SWI-SNF is required for complete occupancy of two low-affinity GAL4 binding sites in vivo. In vivo DMS footprinting was performed on strains that harbor the two-high-affinity-site reporter (A) or the two-low-affinity-site reporter (B). The strains used were as follows: for panel A, CY529 (gal4 parental two-low-affinity-site reporter, cleavage of GAL4 site 3 by HgaI was less efficient, indicating that these sequences are less accessible than they are at GAL1,10. Furthermore, insertion of the NPE upstream of the GAL4 binding sites had a dramatic effect on HgaI cleavage. Cleavage at the NPE-containing reporter locus was at least threefold greater than the parental reporter locus, and the cleavage appeared to be even more efficient than cleavage at the GAL1,10 locus. These differences in HgaI accessibility are not due to the binding of GAL4, since similar results were also obtained when permeabilized spheroplasts were prepared from gal4 deletion strains (data not shown). Thus, the accessibility of GAL4 site 3 to HgaI cleavage correlates well with the nucleosome mapping data and the SWI-SNF dependence of GAL4 activity (Fig. 6 ).
DISCUSSION
In vitro experiments have demonstrated that the SWI-SNF complex can stimulate the binding of an activator protein to a nucleosomal binding site (5, 16 ). Here we have tested whether the complex exhibits this activity in vivo. We have shown that the SWI-SNF complex facilitates the binding of GAL4 to two low-affinity binding sites in vivo. Furthermore, we find that the inability of GAL4 to occupy these low-affinity sites in the absence of SWI-SNF activity can be overcome by (i) replacing the low-affinity binding sites with high-affinity GAL4 binding sites or (ii) placing the low-affinity binding sites into a nucleosomefree region. These results indicate that SWI-SNF is able to facilitate GAL4 binding in vivo, perhaps by helping GAL4 to A definition of SWI-SNF dependence. Our results suggest that the SWI-SNF dependence of a transcriptional activator protein is not an innate feature of the activator protein per se but rather reflects the chromosomal context of the activator binding sites. We propose that when the activator binding sites are encompassed in a nucleosome, as in the two-low-affinitysite reporter used in this study, SWI-SNF function is necessary for the activator protein to bind to and activate transcription from those sites (Fig. 6) . On the other hand, when binding sites are nucleosome-free, as is the case at the GAL1,10 UAS region or at the NPE-containing two-low-affinity-site reporter, then SWI-SNF function is dispensable for GAL4 activity (Fig. 6) . In this case, GAL4 can bind to its sites and activate transcription in the absence of SWI-SNF activity. Furthermore, SWI-SNF dependence does not appear to correlate with the level of transcriptional activation (i.e., promoter strength [ Fig. 1A]) . Thus, based on the results presented here, we predict that the subset of genes whose expression requires SWI-SNF will have activator binding sites that are encompassed in nucleosomes; genes that do not require SWI-SNF will have such sites positioned in the linker regions between nucleosomes or in other nucleosome-free regions. This positioning may be determined by DNA sequence, as in the NPE-containing reporter, or by abundant DNA binding proteins like GRF2, as in the case of the intact GAL1,10 reporter.
Our results also require that binding site affinity be incorporated into the definition of SWI-SNF dependence. While GAL4 requires SWI-SNF in order to access two low-affinity FIG. 5. An NPE leads to enhanced accessibility of a GAL4 binding site. (A) Schematic of the GAL1,10 and reporter loci. The black bar denotes the DNA fragment used as a probe in Southern blotting. The HgaI site is located at the 3Ј end of GAL4 site 3. ϩ/Ϫ NPE, with or without an NPE. (B) HgaI accessibility assay. HgaI was added to nystatin-permeabilized spheroplasts prepared from SWI ϩ strains harboring either the parental two-low-affinity-site reporter (Ϫ NPE; CY532) or the NPE-containing two-low-affinity-site reporter (ϩ NPE; CY586). DNA digested in situ was purified, digested to completion with HindIII, and analyzed by Southern blotting using the DNA probe denoted in panel A. Phosphorimager quantitation of the HgaI-HindIII fragments is shown for the 15-and 30-min HgaI digestion time points. The yields of the 0.5-kb HgaI-HindIII fragments from the two different reporter loci are presented as a percentage of the 1.6-kb HgaI-HindIII fragment derived from the GAL1,10 locus which was set at 100% accessibility.
binding sites, high-affinity sites are occupied even in the absence of SWI-SNF. The ability of higher-affinity binding sites to alleviate SWI-SNF dependence provides strong evidence that the SWI-SNF complex modulates transactivation at the level of DNA binding. Furthermore, if these high-affinity binding sites are encompassed by nucleosomes, then our results suggest that GAL4 binding to high-affinity, nucleosomal sites can occur in vivo via a SWI-SNF-independent mechanism. These results are consistent with those of Workman and Kingston (28) , who found that GAL4 can bind to a nucleosomal site to form a tripartite transcription factor-histone-DNA complex.
Does the SWI-SNF complex play an additional role in transcriptional activation? As noted above, we detect a consistent level of GAL4 binding to the low-affinity sites in the swi1 Ϫ strain (Fig. 3B, compare lanes 5 and 6) ; phosphorimager analysis indicates site 3 may be occupied at 60% of the level seen in a SWI ϩ strain (Fig. 3C ). The fact that this level of occupancy results in negligible levels of transcription (3% of wild-type level [ Fig. 1A, reporter c] ) may indicate a role for the SWI-SNF complex in transcriptional activation beyond the modulation of activator binding. In light of recent reports suggesting that the SWI-SNF complex may associate with the RNA polymerase II holoenzyme (25) , it is interesting to consider the possibility that an activator-SWI-SNF interaction is involved in preinitiation complex assembly. On the other hand, our in vivo footprinting procedure does not allow us to determine the extent to which site 3 and site 4 are simultaneously occupied and we cannot distinguish whether the 60% occupancy in a swi-snf strain reflects the stable binding of GAL4 in 60% of the cells or reflects weak, unstable binding in 100% of the cells. Therefore, our results may support an additional role for the SWI-SNF complex in facilitating the cooperative binding of GAL4 or in enhancing the stability of GAL4 binding to lowaffinity, nucleosomal sites in vivo.
